Roche’s investigational KRAS G12C inhibitor has beaten Amgen’s Lumakras and Bristol Myers Squibb’s Krazati in a phase 3 trial, furthering its ambitions to establish divarasib as a new standard of care ...
After more than 20 years, Novartis has finally decided to sell its substantial share in fellow Swiss pharma group Roche for $20.7 billion, a decent return on its original $5 billion investment. The ...
Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...
LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing machine on Monday, marking a bid by the Swiss drugmaker and diagnostics group to loosen U.S.-based Illumina's grip ...
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist’s market share with its own next-gen platform. Roche’s Axelios 1 delivers ...
Seventy-two years after the Roche family opened a meat market that grew into a Massachusetts supermarket chain, the family is selling a controlling interest in the company to a longtime supplier in ...
Whether you spend a lot of time on your feet for your job or you regularly engage in intense workouts, it’s likely that you’ve experienced sore, aching legs and swollen feet at some point or another.
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Jackie Reeve, Eve O'Neill, and Shannon Palus The pleasant squeeze of ...
When you buy through our links, Business Insider may earn an affiliate commission. Learn more When you spend hours at a standstill, it's harder for blood to circulate back to your heart. It ends up ...
MY RECOVERY ROUTINE has included quality time in my compression boots for a few years now. For a lot of guys (myself included) self care is not a strong suit. For many years I went hard until the ...
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results